Deltanoid Pharmaceuticals
Madison, Wisconsin, United States
About Deltanoid Pharmaceuticals
Deltanoid Pharmaceuticals Inc. is a privately funded biopharmaceutical company based in Madison, Wisconsin, engaged in research, development and commercialization of novel therapies for the treatment of human diseases. The company was founded to advance the development of raw university inventions, with an initial focus on vitamin D analogs and other compounds licensed from the Wisconsin Alumni Research Foundation. Deltanoid's continued focus is to develop selected therapies through early phases of the drug development process and seek partners for later stage development and commercialization in a wide variety of therapeutic areas, including renal disease, osteoporosis, and acne. Currently Deltanoid has a partnership agreement in place with Novadiol, Inc. for development of a vitamin D therapy.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2007)
- Website: deltanoid.com
- Phone: +1 608-238-7710
Industries & Categories
Biopharma, Biotechnology, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/deltanoid-pharmaceuticals-2493206 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.